BRCA1 and pancreatic neoplasm: Although the NGS system allows us to perform extensive molecular analysis on a limited nucleic acid input, the molecular profiling of pancreatic tumor tissues is not yet a part of clinical practice and only few data are available about its feasibility and particularly about BRCA1/2 testing on this type of specimens [22,25].